387 related articles for article (PubMed ID: 34359684)
1. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.
Abdul Rahman R; Lamarca A; Hubner RA; Valle JW; McNamara MG
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359684
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and pancreatic ductal adenocarcinoma.
Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
[TBL] [Abstract][Full Text] [Related]
4. The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer.
Rogers S; Charles A; Thomas RM
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136254
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Microbiome in Pancreatic Cancer.
Miyabayashi K; Ijichi H; Fujishiro M
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139638
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.
Merali N; Chouari T; Kayani K; Rayner CJ; Jiménez JI; Krell J; Giovannetti E; Bagwan I; Relph K; Rockall TA; Dhillon T; Pandha H; Annels NE; Frampton AE
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205769
[TBL] [Abstract][Full Text] [Related]
7. Roles of microbiota in pancreatic cancer development and treatment.
Cruz MS; Tintelnot J; Gagliani N
Gut Microbes; 2024; 16(1):2320280. PubMed ID: 38411395
[TBL] [Abstract][Full Text] [Related]
8. The microbiota and microbiome in pancreatic cancer: more influential than expected.
Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
[TBL] [Abstract][Full Text] [Related]
9. The Microbiome in PDAC-Vantage Point for Future Therapies?
Pfisterer N; Lingens C; Heuer C; Dang L; Neesse A; Ammer-Herrmenau C
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497456
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
11. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Mendez R; Kesh K; Arora N; Di Martino L; McAllister F; Merchant N; Banerjee S; Banerjee S
Carcinogenesis; 2020 Jul; 41(5):561-570. PubMed ID: 31369062
[TBL] [Abstract][Full Text] [Related]
12. The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data.
Yu D; Wang T; Liang D; Mei Y; Zou W; Guo S
Front Oncol; 2021; 11():651350. PubMed ID: 34136388
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
14. Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development.
Bellotti R; Speth C; Adolph TE; Lass-Flörl C; Effenberger M; Öfner D; Maglione M
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298645
[TBL] [Abstract][Full Text] [Related]
15. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.
Basu M; Philipp LM; Baines JF; Sebens S
Front Oncol; 2021; 11():740606. PubMed ID: 34631577
[TBL] [Abstract][Full Text] [Related]
16. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota.
Perelló-Reus CM; Rubio-Tomás T; Cisneros-Barroso E; Ibargüen-González L; Segura-Sampedro JJ; Morales-Soriano R; Barceló C
Front Oncol; 2022; 12():995357. PubMed ID: 36531066
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding pancreatic cancer.
Stott MC; Oldfield L; Hale J; Costello E; Halloran CM
Fac Rev; 2022; 11():9. PubMed ID: 35509672
[TBL] [Abstract][Full Text] [Related]
18. Fungi, host immune response, and tumorigenesis.
Elaskandrany M; Patel R; Patel M; Miller G; Saxena D; Saxena A
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G213-G222. PubMed ID: 34231392
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind.
Arsenijevic T; Nicolle R; Bouchart C; D'Haene N; Demetter P; Puleo F; Van Laethem JL
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799784
[TBL] [Abstract][Full Text] [Related]
20. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer.
Guo W; Zhang Y; Guo S; Mei Z; Liao H; Dong H; Wu K; Ye H; Zhang Y; Zhu Y; Lang J; Hu L; Jin G; Kong X
Commun Biol; 2021 Aug; 4(1):1019. PubMed ID: 34465850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
